0001193125-22-274061.txt : 20221031 0001193125-22-274061.hdr.sgml : 20221031 20221031171904 ACCESSION NUMBER: 0001193125-22-274061 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221031 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221031 DATE AS OF CHANGE: 20221031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Addus HomeCare Corp CENTRAL INDEX KEY: 0001468328 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 205340172 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34504 FILM NUMBER: 221347151 BUSINESS ADDRESS: STREET 1: 6303 COWBOYS WAY STREET 2: SUITE 600 CITY: FRISCO STATE: TX ZIP: 75034 BUSINESS PHONE: 469-535-8200 MAIL ADDRESS: STREET 1: 6303 COWBOYS WAY STREET 2: SUITE 600 CITY: FRISCO STATE: TX ZIP: 75034 8-K 1 d405906d8k.htm 8-K 8-K
Addus HomeCare Corp false 0001468328 0001468328 2022-10-31 2022-10-31

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 31, 2022

 

 

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-34504   20-5340172

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

6303 Cowboys Way, Suite 600

Frisco, Texas

  75034
(Address of principal executive offices)   (Zip Code)

(469) 535-8200

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.001 par value per share   ADUS   The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company.  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 2.02

Results of Operations and Financial Condition.

On October 31, 2022, Addus HomeCare Corporation (the “Company”) issued a press release (the “Press Release”) announcing, among other matters, the Company’s results of operations for the fiscal quarter ended September 30, 2022. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this report and is incorporated herein by reference.

 

Item 7.01.

Regulation FD Disclosure

On October 31, 2022, the Company issued the Press Release, announcing, among other matters, its results of operations for the fiscal quarter ended September 30, 2022, the text of which is set forth as Exhibit 99.1.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits:

 

Exhibit

No.

   Description
99.1    Press Release of Addus HomeCare Corporation dated October 31, 2022.
104    Cover Page Interactive Data File (embedded within Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ADDUS HOMECARE CORPORATION
Date: October 31, 2022     By:  

/s/ Brian Poff

      Brian Poff
      Chief Financial Officer
EX-99.1 2 d405906dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

 

Contacts:   
Brian W. Poff    Dru Anderson
Executive Vice President, Chief Financial Officer    FINN Partners
Addus HomeCare Corporation    (615) 324-7346
(469) 535-8200    dru.anderson@finnpartners.com
investorrelations@addus.com   

ADDUS HOMECARE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS

Frisco, Texas (October 31, 2022) – Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2022.

Third Quarter 2022 Highlights:

 

   

Revenues Grow 11.0% to $240.5 Million

 

   

Net Income of $11.5 Million, or $0.71 per Diluted Share

 

   

Adjusted Earnings per Diluted Share Increases to $0.94

 

   

Adjusted EBITDA Increases 3.4% to $25.7 Million

 

   

Cash flow from operations of $18.3 Million

Overview

Net service revenues were $240.5 million for the third quarter of 2022, an 11.0% increase compared with $216.7 million for the third quarter of 2021. Net income was $11.5 million for the third quarter of 2022, compared with $11.6 million for the third quarter of 2021, while net income per diluted share was $0.71 compared with $0.72 for the same period a year ago. Adjusted EBITDA increased 3.4% to $25.7 million for the third quarter of 2022 from $24.9 million for the third quarter of 2021. Adjusted net income per diluted share was $0.94 for the third quarter of 2022 compared with $0.91 for the third quarter of 2021. Adjusted net income per diluted share for the third quarter of 2022 excludes acquisition and de novo expenses of $0.08, restructure and other non-recurring costs of $0.01 and stock-based compensation expense of $0.14. (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)

For the first nine months of 2022, net service revenues increased 10.0% to $704.1 million from $639.9 million for the prior-year period. Net income was $31.3 million for the first nine months of 2022 compared with $32.1 million for the same period in 2021, and net income per diluted share was $1.94 compared with $2.00 per diluted share. Adjusted net income was $42.3 million compared with $42.0 million for the first nine months of 2021, while adjusted net income per diluted share was $2.63 compared with $2.62 for the prior-year period. Adjusted EBITDA increased 4.7% to $73.2 million for the first nine months of 2022 from $69.9 million for the first nine months of 2021.

Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “Addus continues to produce strong financial and operating results, and we were pleased with our ability to execute on our strategy in the current environment. Our overall revenue growth of 11.0% over the third quarter of the prior year reflects favorable trends in each of our operating segments. Personal care revenues, which accounted for 74.5% of overall revenue, were up 7.0% on a same-store basis. For our home health business, we achieved an 18.6% organic growth rate in new admissions and total volumes were up 15.1% on a same store basis. Total home health revenues increased 25.1% from the prior year and include the addition of the operations of Armada Home Health and Summit Home Health that were both acquired in 2021. We are excited about the growth opportunities in our home health operations as it complements our personal care services and supports our value-based care models. We also saw steady improvement in our hospice business, which accounted for 21.4% of revenues for the third quarter and included the acquired operations of JourneyCare, which were added as of February 1, 2022, and are now fully integrated. Total hospice revenues were up 31.4% over the third quarter of 2021, and our median length of stay increased from 23 days in the second quarter to 28 days in the third quarter.

 

-MORE-


ADUS Announces Third-Quarter 2022 Financial Results

Page 2

October 31, 2022

 

“As we end the third quarter, we are proud of the excellent job our team has done to date during 2022 despite various challenges, including the impact of Omicron, which was especially acute during the first quarter, and industry-wide staffing headwinds throughout the year. While the clinical recruiting and retention dynamics remain challenging, we are seeing clinical hiring trends start to move in a positive direction. Our overall hiring and turnover trends in personal care have also continued to improve during the third quarter, and we continue to evaluate and invest in enhancing our recruiting and onboarding processes to best position Addus to meet current and expected demand for our services.

“We remain strategic in our efforts to grow our existing business organically while actively pursuing additional growth through acquisitions. On October 1, 2022, we completed the acquisition of Apple Home Healthcare, LTD (“Apple”), which serves an average daily census of approximately 450 home health patients in an 11-county area in and around Chicago, Illinois. This transaction aligns with our strategy of expanding clinical services in existing personal care markets so that we can provide all three levels of home care with geographic scale and density. Together with our recent acquisitions of Summit Home Health and JourneyCare Hospice in the greater Chicago area, we have extended our market coverage in both clinical care segments. We are excited to welcome the experienced Apple operations team and clinical staff to Addus, and we look forward to serving more patients in this important market.”

Cash and Liquidity

The Company has focused on maintaining a strong financial position in 2022. As of September 30, 2022, the Company had cash of $105.6 million, with capacity and availability under its revolving credit facility of $375.5 million and $200.5 million, respectively. Net cash provided by operating activities was $18.3 million for the third quarter of 2022.

Looking Ahead

Allison added, “We are pleased with the trends in our business and believe that we are well positioned to drive further growth. With the completion of the Apple transaction, we have added approximately $65 million in annualized revenues through acquisitions to date in 2022. Our experienced and capable development team has assembled a robust pipeline of acquisition opportunities, and we have the capital structure and liquidity to support our growth strategy and further strengthen our competitive market position.

“We remain especially proud of our team’s dedicated work, particularly our frontline caregivers, who provide outstanding care and support for our patients and their families. They continue to respond to the growing demand for our services, delivered in the safest and most cost-effective setting. We have a proven operating model across the care continuum that supports favorable outcomes and patient satisfaction. We believe we are well positioned to build on this model, and we look forward to the opportunities ahead for Addus,” said Allison.

Non-GAAP Financial Measures

The information provided in this release includes adjusted net income, adjusted EBITDA and adjusted net income per diluted share, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition and de novo expenses, stock-based compensation expenses, restructure and other non-recurring costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. The Company defines adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition and de novo expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. The Company defines adjusted diluted earnings per share as earnings per share, adjusted for acquisition and de novo expenses, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets, and retroactive rate increases from Illinois. The Company defined adjusted net income, adjusted EBITDA, adjusted diluted earnings per share to exclude net COVID expenses arising from the pandemic from the second quarter of 2020 to the first quarter of 2021. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted earnings per share to earnings per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP

 

-MORE-


ADUS Announces Third-Quarter 2022 Financial Results

Page 3

October 31, 2022

 

measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted earnings per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company’s operating performance, to provide investors with insight and consistency in the Company’s financial reporting and to present a basis for comparison of the Company’s business operations among periods, and to facilitate comparison with the results of the Company’s peers.

Conference Call

Addus will host a conference call on Tuesday, November 1, 2022, at 9:00 a.m. Eastern time. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on November 8, 2022, by dialing 1-877-344-7529 (international dial-in number is (412) 317-0088) and entering pass code 4223751.

A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast.

Forward-Looking Statements

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, anticipated transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any future impact to our business operations, reimbursements and patient population due to the recent COVID-19 global pandemic, and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 25, 2022, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).

About Addus HomeCare

Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals. Addus HomeCare currently provides home care services to approximately 46,500 consumers through 207 locations across 22 states. For more information, please visit www.addus.com.

 

-MORE-


ADUS Announces Third-Quarter 2022 Financial Results

Page 4

October 31, 2022

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(amounts and shares in thousands, except per share data)

(Unaudited)

 

Income Statement Information:    For the Three Months
Ended September 30,
    For the Nine Months
Ended September 30,
 
     2022     2021     2022     2021  

Net service revenues

   $ 240,495     $ 216,662     $ 704,070     $ 639,857  

Cost of service revenues

     165,310       149,616       483,100       442,804  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     75,185       67,046       220,970       197,053  
     31.3     30.9     31.4     30.8

General and administrative expenses

     54,228       46,280       162,476       139,881  

Depreciation and amortization

     3,441       3,406       10,571       10,594  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     57,669       49,686       173,047       150,475  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     17,516       17,360       47,923       46,578  

Total interest expense, net

     2,389       1,577       6,029       4,002  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     15,127       15,783       41,894       42,576  

Income tax expense

     3,584       4,206       10,631       10,508  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 11,543     $ 11,577     $ 31,263     $ 32,068  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per diluted share:

   $ 0.71     $ 0.72     $ 1.94     $ 2.00  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of common shares outstanding:

        

Diluted

     16,184       16,030       16,146       16,060  
Cash Flow Information:    For the Three Months
Ended September 30,
    For the Nine Months
Ended September 30,
 
     2022     2021     2022     2021  

Net cash provided by operating activities

   $ 18,316     $ 17,608     $ 80,818     $ 14,287  

Net cash (used in) investing activities

     (1,326     (30,505     (87,354     (32,433

Net cash (used in) provided by financing activities

     (32,263     25,876       (56,715     25,447  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net change in cash

     (15,273     12,979       (63,251     7,301  

Cash at the beginning of the period

     120,917       139,400       168,895       145,078  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash at the end of the period

   $ 105,644     $ 152,379     $ 105,644     $ 152,379  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

-MORE-


ADUS Announces Third-Quarter 2022 Financial Results

Page 5

October 31, 2022

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(Amounts in thousands)

(Unaudited)

 

     September 30,  
     2022      2021  

Assets

     

Current assets

     

Cash

   $ 105,644      $ 152,379  

Accounts receivable, net

     126,253        133,814  

Prepaid expenses and other current assets

     8,245        13,514  
  

 

 

    

 

 

 

Total current assets

     240,142        299,707  
  

 

 

    

 

 

 

Property and equipment, net

     17,428        18,614  
  

 

 

    

 

 

 

Other assets

     

Goodwill

     575,205        497,919  

Intangible assets, net

     72,655        66,332  

Deferred tax assets, net

     —          5,919  

Operating lease assets

     40,503        36,424  
  

 

 

    

 

 

 

Total other assets

     688,363        606,594  
  

 

 

    

 

 

 

Total assets

   $ 945,933      $ 924,915  
  

 

 

    

 

 

 

Liabilities and stockholders’ equity

     

Current liabilities

     

Accounts payable

   $ 19,545      $ 23,167  

Accrued payroll

     35,084        31,626  

Accrued expenses

     39,557        35,780  

Government stimulus advance

     21,158        7,674  

Accrued workers compensation

     12,844        14,286  
  

 

 

    

 

 

 

Total current liabilities

     128,188        112,533  

Long-term debt, less current portion, net of debt issuance costs

     163,557        220,707  

Long-term lease liability, less current portion

     37,168        33,509  

Other long-term liabilities

     2,183        115  
  

 

 

    

 

 

 

Total long-term liabilities

     202,908        254,331  
  

 

 

    

 

 

 

Total liabilities

     331,096        366,864  
  

 

 

    

 

 

 

Total stockholders’ equity

     614,837        558,051  
  

 

 

    

 

 

 

Total liabilities and stockholders’ equity

   $ 945,933      $ 924,915  
  

 

 

    

 

 

 

 

-MORE-


ADUS Announces Third-Quarter 2022 Financial Results

Page 6

October 31, 2022

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Net Service Revenue by Segment

(Amounts in thousands)

(Unaudited)

 

     For the Three Months
Ended September 30,
     For the Nine Months
Ended September 30,
 
     2022      2021      2022      2021  

Net Service Revenues by Segment

           

Personal Care

   $ 179,180      $ 169,609      $ 523,142      $ 510,744  

Hospice

     51,359        39,095        151,160        112,098  

Home Health

     9,956        7,958        29,768        17,015  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 240,495      $ 216,662      $ 704,070      $ 639,857  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

-MORE-


ADUS Announces Third-Quarter 2022 Financial Results

Page 7

October 31, 2022

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Key Statistical and Financial Data (Unaudited)

 

     For the Three Months
Ended September 30,
    For the Nine Months
Ended September 30,
 
     2022     2021     2022     2021  

Personal Care

        

States served at period end

     —         —         21       22  

Locations at period end

     —         —         161       162  

Average billable census total

     37,677       37,979       37,253       38,266  

Billable hours (in thousands)

     7,473       7,537       21,947       22,712  

Average billable hours per census per month

     65.9       65.8       65.2       65.7  

Billable hours per business day

     113,229       114,195       112,547       116,472  

Revenues per billable hour

   $ 23.92     $ 22.47     $ 23.71     $ 22.45

Organic growth

        

- Revenue

     7.0     4.0     3.5     6.6  

Hospice

        

Locations served at period end

     —         —         33       34  

Admissions

     3,182       2,565       9,778       7,211  

Average daily census

     3,280       2,629       3,304       2,523  

Average discharge length of stay

     92.7       95.2       86.8       95.4  

Patient days

     301,797       240,692       880,574       680,600  

Revenue per patient day

   $ 170.18     $ 162.43     $ 171.66     $ 164.71

Organic growth

               

- Revenue

     0.1     (4.8 )%      1.6     (7.2

- Average daily census

     2.2     (7.6 )%      5.0     (24.6

Home Health

        

Locations served at period end

     —         —         12       11  

New Admissions

     3,684       2,608       10,371       4,962  

Recertifications

     1,482       1,081       4,207       2,476  

Total Volume

     5,166       3,689       14,578       7,438  

Visits

     71,670       55,963       205,335       115,210

Organic growth

               

- Revenue

     0.2     24.8     (1.2 )%      15.9

- New admissions

     18.6     27.9     15.7     23.8  

- Volume

     15.1     29.8     16.0     18.2  

Percentage of Revenues by Payor:

        

Personal Care

               

State, local and other governmental programs

     49.4     49.5     49.4     49.5  

Managed care organizations

     46.4       45.3       46.1       45.3  

Private duty

     2.6       2.9       2.6       2.9

Commercial

     1.0       1.4       1.1       1.5  

Other

     0.6     0.9     0.8     0.8  

Hospice

               

Medicare

     90.6     92.8     90.8     93.4  

Commercial

     5.4       3.0       5.1       2.4

Managed care organizations

     3.5       3.9       3.6       3.9  

Other

     0.5     0.3     0.5     0.3  

Home Health

               

Medicare

     73.5     80.1     73.0     80.5  

Managed care organizations

     20.1       15.3       20.7       16.7

Commercial

     6.2       4.4       6.1       2.8  

Other

     0.2     0.2     0.2     0.0  

 

-MORE-


ADUS Announces Third-Quarter 2022 Financial Results

Page 8

October 31, 2022

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Reconciliation of Non-GAAP Financial Measures

(amounts in thousands, except per share data)

(Unaudited) (1)

 

     For the Three Months
Ended September 30,
    For the Nine Months
Ended September 30,
 
     2022     2021     2022     2021  

Reconciliation of Adjusted EBITDA to Net Income: (2)

        

Net income

   $ 11,543     $ 11,577     $ 31,263     $ 32,068  

Interest expense, net

     2,389       1,577       6,029       4,002  

(Gain) Loss on sale of assets

     (25     —         (27     16  

Income tax expense

     3,584       4,206       10,631       10,508  

Depreciation and amortization

     3,441       3,406       10,571       10,594  

COVID-19 expense, net

     —         —         —         (591

Acquisition and de novo expenses

     1,878       1,663       6,502       5,383  

Stock-based compensation expense

     2,780       2,341       7,945       7,105  

Restructure and other non-recurring costs

     132       103       318       857  
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 25,722     $ 24,873     $ 73,232     $ 69,942  
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of Adjusted Net Income to Net Income: (3)

        

Net income

   $ 11,543     $ 11,577     $ 31,263     $ 32,068  

(Gain) Loss on sale of assets, net of tax

     (18     —         (20     12  

COVID-19 expense, net of tax

     —         —         —         (479

Acquisition and de novo expenses, net of tax

     1,444       1,220       4,852       4,361  

Stock-based compensation expense, net of tax

     2,124       1,716       5,928       5,370  

Restructure and other non-recurring costs, net of tax

     101       76       237       647  
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted Net Income

   $ 15,194     $ 14,589     $ 42,260     $ 41,979  
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (4)

 

   

Net income per diluted share

   $ 0.71     $ 0.72     $ 1.94     $ 2.00  

COVID-19 expense, net per diluted share

     —         —         —         (0.02

Acquisition and de novo expenses per diluted share

     0.08       0.08       0.30       0.27  

Restructure and other non-recurring costs per diluted share

     0.01       —         0.01       0.04  

Stock-based compensation expense per diluted share

     0.14       0.11       0.38       0.33  
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net income per diluted share

   $ 0.94     $ 0.91     $ 2.63     $ 2.62  
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (5)

 

     

Net service revenues

   $ 240,495     $ 216,662     $ 704,070     $ 639,857  

Revenues associated with the closure of certain sites

     0       (529     0       (1,816
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net service revenues

   $ 240,495     $ 216,133     $ 704,070     $ 638,041  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

-MORE-


ADUS Announces Third-Quarter 2022 Financial Results

Page 9

October 31, 2022

 

Footnotes:

 

(1)

The Company defined adjusted net income, adjusted EBITDA, and adjusted diluted earnings per share to exclude net COVID expenses arising from the pandemic from the second quarter of 2020 to the first quarter of 2021.

(2)

We define Adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition and de novo expense, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets and retroactive rate increases from Illinois. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

(3)

We define Adjusted Net Income as net income before acquisition and de novo expenses, stock-based compensation expenses, restructure and other non-recurring costs, gain or loss on the sale of assets and retroactive rate increases from Illinois. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

(4)

We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition and de novo expenses, stock-based compensation expense, restructure and other non-recurring costs, gain or loss on the sale of assets and retroactive rate increases from Illinois. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

(5)

We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

 

-END-

EX-101.SCH 3 adus-20221031.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 adus-20221031_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 adus-20221031_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g405906g1031234302965.jpg GRAPHIC begin 644 g405906g1031234302965.jpg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htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information
Oct. 31, 2022
Cover [Abstract]  
Entity Registrant Name Addus HomeCare Corp
Amendment Flag false
Entity Central Index Key 0001468328
Document Type 8-K
Document Period End Date Oct. 31, 2022
Entity Incorporation State Country Code DE
Entity File Number 001-34504
Entity Tax Identification Number 20-5340172
Entity Address, Address Line One 6303 Cowboys Way
Entity Address, Address Line Two Suite 600
Entity Address, City or Town Frisco
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75034
City Area Code (469)
Local Phone Number 535-8200
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value per share
Trading Symbol ADUS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 d405906d8k_htm.xml IDEA: XBRL DOCUMENT 0001468328 2022-10-31 2022-10-31 Addus HomeCare Corp false 0001468328 8-K 2022-10-31 DE 001-34504 20-5340172 6303 Cowboys Way Suite 600 Frisco TX 75034 (469) 535-8200 false false false false Common Stock, $0.001 par value per share ADUS NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName - d405906d8k.htm 7 d405906d8k.htm adus-20221031.xsd adus-20221031_lab.xml adus-20221031_pre.xml d405906dex991.htm http://xbrl.sec.gov/dei/2021 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d405906d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d405906d8k.htm" ] }, "labelLink": { "local": [ "adus-20221031_lab.xml" ] }, "presentationLink": { "local": [ "adus-20221031_pre.xml" ] }, "schema": { "local": [ "adus-20221031.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "adus", "nsuri": "http://www.addus.com/20221031", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d405906d8k.htm", "contextRef": "duration_2022-10-31_to_2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d405906d8k.htm", "contextRef": "duration_2022-10-31_to_2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.addus.com//20221031/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001193125-22-274061-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-274061-xbrl.zip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